Definitive Healthcare (NASDAQ:DH) Issues FY 2025 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 0.190-0.220 for the period, compared to the consensus earnings per share estimate of 0.290. The company issued revenue guidance of $230.0 million-$240.0 million, compared to the consensus revenue estimate of $241.2 million. Definitive Healthcare also updated its Q1 2025 guidance to 0.020-0.020 EPS.

Analyst Ratings Changes

A number of research analysts recently issued reports on the company. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a report on Thursday, January 16th. Barclays restated an “underweight” rating and set a $4.00 target price on shares of Definitive Healthcare in a report on Monday, January 13th. Finally, Stephens started coverage on shares of Definitive Healthcare in a report on Friday, December 20th. They issued an “equal weight” rating and a $5.00 price target on the stock. Two research analysts have rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, Definitive Healthcare has a consensus rating of “Hold” and a consensus target price of $5.72.

Definitive Healthcare Stock Down 3.5 %

NASDAQ:DH opened at $4.92 on Friday. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49. The firm’s 50-day moving average price is $4.63 and its 200-day moving average price is $4.47. The company has a market capitalization of $568.37 million, a PE ratio of -1.59, a P/E/G ratio of 4.06 and a beta of 1.45. Definitive Healthcare has a 1-year low of $3.19 and a 1-year high of $10.62.

Definitive Healthcare (NASDAQ:DH) last announced its earnings results on Thursday, February 27th. The company reported $0.03 earnings per share for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.04). Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. On average, equities analysts predict that Definitive Healthcare will post 0.16 EPS for the current fiscal year.

Insider Activity at Definitive Healthcare

In other Definitive Healthcare news, insider William Moschella sold 45,000 shares of the stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total transaction of $211,500.00. Following the sale, the insider now directly owns 433,830 shares in the company, valued at approximately $2,039,001. This trade represents a 9.40 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 14.84% of the stock is currently owned by insiders.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.